西隴科學(002584.SZ):擬向全資子公司增資
格隆匯11月29日丨西隴科學(002584.SZ)公佈,為提高公司全資子公司雲南盈和新能源材料有限公司(簡稱“雲南盈和”)、廣州市西隴化工有限公司(簡稱“廣州西隴”)、上海西隴化工有限公司(簡稱“上海西隴”)的綜合競爭力,促進公司及子公司整體的良性運營和可持續發展,公司擬通過現金方式向子公司雲南盈和增資10000萬元人民幣、向廣州西隴增資7900萬元人民幣、向上海西隴增資3000萬元人民幣。增資完成後上述子公司仍為公司的全資子公司。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.